HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Prostaglandin H2 (PGH(2))

A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins.
Also Known As:
PGH(2); PGH2; Prosta-5,13-dien-1-oic acid, 9,11-epidioxy-15-hydroxy-, (5Z,9alpha,11alpha,13E,15S)-
Networked: 114 relevant articles (4 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Urade, Yoshihiro: 4 articles (10/2008 - 12/2002)
2. Inoue, Tsuyoshi: 3 articles (10/2007 - 12/2002)
3. Matsumura, Hiroyoshi: 3 articles (10/2007 - 12/2002)
4. Cummins, Robert: 2 articles (05/2014 - 01/2011)
5. Pidgeon, Graham P: 2 articles (05/2014 - 01/2011)
6. O'Byrne, Kenneth J: 2 articles (05/2014 - 01/2011)
7. Gately, Kathy: 2 articles (05/2014 - 01/2011)
8. Werz, Oliver: 2 articles (03/2011 - 08/2009)
9. FitzGerald, Garret A: 2 articles (08/2010 - 07/2010)
10. Wang, Miao: 2 articles (08/2010 - 07/2010)

Related Diseases

1. Thrombosis (Thrombus)
2. Hypertension (High Blood Pressure)
3. Coronary Occlusion
4. Coronary Stenosis (Coronary Artery Stenosis)
5. Atherosclerosis

Related Drugs and Biologics

1. Prostaglandin H2 (PGH(2))
2. Thromboxane A2 (A2, Thromboxane)
3. Aspirin (Acetylsalicylic Acid)
4. Serotonin (5 Hydroxytryptamine)
5. Sodium
6. Tissue Plasminogen Activator (Alteplase)
7. Epinephrine (Adrenaline)
8. KW 3635
9. Arachidonic Acid (Vitamin F)
10. Prostaglandins E (PGE)

Related Therapies and Procedures

1. Transplants (Transplant)
2. Transplantation (Transplant Recipients)
3. Electrodes (Electrode)
4. Aftercare (After-Treatment)
5. Oral Administration